Abstract:We have previously shown that Toll-like receptor (TLR)-activated murine nonparenchymal liver cells [(NPC); Kupffer cells (KC), liver sinusoidal endothelial cells (LSEC)] can suppress hepatitis B virus (HBV) replication. Therefore, the aim of this study was to investigate whether HBV has the ability to counteract the TLR-mediated control of its replication. Freshly purified murine hepatocytes and NPCs obtained from C57BL6 mice were stimulated by TLR 1-9 ligands in the presence or absence of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), HBV virions, or supernatants from HBV-producing HBV-Met cells, and HBV replication was suppressed by anti-hepatitis B virus X protein (HBx) small interfering RNA (siRNA) in HBV-Met cells. Supernatants were collected and tested for antiviral cytokines by viral protection assay. HBV gene expression and replication was analyzed by southern blot. RNA and proteins were analyzed by quantitative reverse transcription polymerase chain reaction (RT-PCR) or western blot and enzyme-linked immunosorbent assay, respectively. Pretreatment of hepatocytes and NPCs with HBV-Met cells supernatants, HBsAg, HBeAg, or HBV virions almost completely abrogated TLR-induced antiviral activity, which correlated with suppression of interferon beta (IFN-beta) production and subsequent interferon-stimulated gene induction as well as suppressed activation of interferon regulatory factor 3 (IRF-3), nuclear factor kappa B (NF-kappa B), and extracellular signal-regulated kinase (ERK) 1/2. In HBV-infected HBV-Met cells, TLR stimulation did not induce antiviral cytokines in contrast to primary hepatocytes. TLR-stimulated expression of proinflammatory cytokines [tumor necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6)], and activation of IRF-3 was suppressed after up-regulation of HBV replication in HBV-Met cells. Accordingly, suppression of HBV replication by siRNA led to activation or expression of proinflammatory transcription factors and cytokines. Conclusion: Our data indicate that HBV can suppress the TLR-induced antiviral activity of liver cells. This has major implications for the interaction between HBV and the immune system. (HEPATOLOGY 2009;49:1132-1140.)

Toll-Like Receptor Activated Human and Murine Hepatic Stellate Cells Are Potent Regulators of Hepatitis C Virus Replication

Hepatic Stellate Cells, Liver Innate Immunity, and Hepatitis C Virus.

Toll-like Receptor Dependent Innate Immune Responses by Primary Mouse Hepatocytes and Its Control of HBV Replication

TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells

Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes

Toll-like receptors and hepatitis C virus infection

HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection

Hepatitis C Virus Improves Human Tregs Suppressive Function and Promotes Their Recruitment to the Liver

Hepatitis B Virus Suppresses Toll-Like Receptor-Mediated Innate Immune Responses in Murine Parenchymal and Nonparenchymal Liver Cells

Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.

Expression of Fc Fragment Receptors of Immunoglobulin G (fcγrs) in Rat Hepatic Stellate Cells

Hepatitis C Virus Impairs TLR3 Signaling and Inhibits IFN-λ 1 Expression in Human Hepatoma Cell Line

Hepatitis C Virus Core Protein Triggers Expansion and Activation of CD4+CD25+ Regulatory T Cells in Chronic Hepatitis C Patients

Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Regulate T-Cell Differentiation And Function Via The Signal Transducer And Activator Of Transcription 3 Pathway

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

Activated Hepatic Stellate Cells Promote Expression of Regulatory T Cells

HCV Dsrna-Activated Macrophages Inhibit HCV Replication in Hepatocytes

Contribution of Toll-Like Receptors to the Control of Hepatitis B Virus Infection by Initiating Antiviral Innate Responses and Promoting Specific Adaptive Immune Responses

Hepatic T Cell Suppressors and Their Inhibition Roles in Hepatic Viral Clearance (P6353)

Inhibition of T-cell Responses by Hepatic Stellate Cells Via B7-H1-mediated T-cell Apoptosis in Mice.

Liver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models.